{
  "Statins": {
    "calculation_period": 10,
    "discount_rate_illness": 0.03,
    "discount_rate_treatment": 0.03,
    "discount_rate_post_treatment": 0.03,
    "illness_utility": 0.66,
    "active_treatment_utility": 0.82,
    "post_treatment_utility": 0.82,
    "treatment_duration": 10,
    "mortality_rate_no_treatment": 0.020,
    "mortality_rate_during_treatment": 0.010,
    "mortality_rate_post_treatment": 0.010,
    "initial_population": 14000
  },
  "Ezetimibe": {
    "calculation_period": 10,
    "discount_rate_illness": 0.03,
    "discount_rate_treatment": 0.03,
    "discount_rate_post_treatment": 0.03,
    "illness_utility": 0.66,
    "active_treatment_utility": 0.79,
    "post_treatment_utility": 0.79,
    "treatment_duration": 10,
    "mortality_rate_no_treatment": 0.020,
    "mortality_rate_during_treatment": 0.011,
    "mortality_rate_post_treatment": 0.011,
    "initial_population": 1000
  },
  "PCSK9 Inhibitors": {
    "calculation_period": 10,
    "discount_rate_illness": 0.03,
    "discount_rate_treatment": 0.03,
    "discount_rate_post_treatment": 0.03,
    "illness_utility": 0.66,
    "active_treatment_utility": 0.85,
    "post_treatment_utility": 0.85,
    "treatment_duration": 10,
    "mortality_rate_no_treatment": 0.020,
    "mortality_rate_during_treatment": 0.009,
    "mortality_rate_post_treatment": 0.009,
    "initial_population": 100
  }
}
